Andrew Jensen
Kvp Capital Advisors, Lp
Assets Managed
$133.897M
Holdings
32
Last Quarter
2026 - Q1
Filed Date
13d ago
Growth Rate
29.57%(2Q avg: 14.79%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Kvp Capital Advisors, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 32 positions.
Assets under management
The assets under management (AUM) of Kvp Capital Advisors, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 133.897M in assets, with a quarterly growth rate of 29.57% and a 2-quarter average growth rate of 14.79%. The portfolio is managed by Andrew Jensen, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
TERN Terns Pharmaceuticals Inc
| 17.33% | $23.197M 440,000 shares@ $52.72 avg price | |
PRAX Praxis Precision Medicines I
| 10.33% | $13.822M 42,900 shares@ $322.19 avg price | |
AADI Aadi Bioscience Inc
| 5.59% | $7.473M 2.166M shares@ $3.46 avg price | |
AXSM Axsome Therapeutics Inc
| 4.57% | $6.119M 36,200 shares@ $169.02 avg price | |
STRO Sutro Biopharma Inc
| 4.22% | $5.644M 226,575 shares@ $24.91 avg price | New Position |
PTGX Protagonist Therapeutics Inc
| 4.18% | $5.586M 53,000 shares@ $105.4 avg price | |
ERAS Erasca Inc
| 4.11% | $5.501M 340,000 shares@ $16.18 avg price | New Position |
TRVI Trevi Therapeutics Inc
| 3.69% | $4.939M 414,000 shares@ $11.93 avg price | |
TNGX Tango Therapeutics Inc
| 3.6% | $4.817M 230,264 shares@ $20.93 avg price | New Position |
INSM Insmed Inc
| 3.49% | $4.66M 28,497 shares@ $163.52 avg price |
1-10 of 32